Pharmacodynamics effect of nerve growth factor-loaded nanoparticles to induce PC12 cells

Chinese Journal of Tissue Engineering Research

Volumn 17, Issue 16, 2013, Pages 2891-2898

  Bao, Guo qing ^a   Long, Da hong ^a   Chen, Yan ^a   Liu, Fei fei ^a   Zhang, Jun du ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biomaterials; Complex emulsion solvent diffusion method; Nano drugs; Nanobiomaterials; Nanoparticles; Nerve growth factor; PC12 cells; Polyethylene glycol polylactic acid glycolic acid copolymer; Provincial grants supported paper

Indexed keywords

BOVINE SERUM ALBUMIN; COPOLYMER; NANOCARRIER; NERVE GROWTH FACTOR; POLYETHYLENE GLYCOL POLYLACTIC ACID GLYCOLIC ACID COPOLYMER NANOPARTICLE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CELL DIFFERENTIATION; DISPERSION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; FLUORESCENCE MICROSCOPE; IN VITRO STUDY; LOAD CARRYING CAPACITY; NANOEMULSION; NANOENCAPSULATION; NANOPHARMACEUTICS; PARTICLE SIZE; PC12 CELL LINE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SLOW DRUG RELEASE; SUSTAINED DRUG RELEASE;

EID: 84940316825     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-4344.2013.16.006     Document Type: Article

References (22)

1. Kirkland RA, Saavedra GM, Franklin JL. Rapid activation of antioxidant defenses by nerve growth factor suppresses reactive oxygen species during neuronal apoptosis: evidence for a role in cytochrome c redistribution. J Neurosci. 2007; 27(42):11315-11326.
2. Colafrancesco V, Villoslada P. Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases. Arch Ital Biol. 2011;149(2):183-192.
3. Shi ED, Wang BC, Sun QS. Nerve growth factor and injured peripheral nerve regeneration. Neural Negen Res 2008;3(11): 1273-1276.
4. Urbaniak A. p75NTR receptor--role in cell growth and apoptosis. Postepy Hig Med Dosw (Online). 2012;66:304-310.
5. Allen SJ, Watson JJ, Dawbarn D. The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol. 2011;9(4): 559-573.
6. Takeda A, Loveman E, Clegg A, et al. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry. 2006;21(1): 17-28.
7. Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008; 60(2): 196-209.
8. Akhlaghi SP, Saremi S, Ostad SN, et al. Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomedicine. 2010;6(5):689-697.
9. Xu F, Lu W, Wu H, et al. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles. J Drug Target. 2009;17(6):423-434.
10. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today. 2008;13 (23-24):1099-1106.
11. Yu DH, Lu Q, Xie J, et al. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials. 2010;31(8):2278-2292.
12. Lemoine D, Francois C, Kedzierewicz F, et al. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D, L-lactide) and poly(D, L-lactide-co-glycolide). Biomaterials. 1996;17(22):2191-2197.
13. Hu S, Zhang Y. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation. Int J Nanomedicine. 2010;5: 1039-1048.
14. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290(1-2):137-144.
15. Xie S, Wang S, Zhao B, et al. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2008;67(2): 199-204.
16. Mei L, Long DH, Huang WD. Jiepo Xue Yanjiu. 2010;32(1): 1-5.
17. Liu FF, Long DH. Jiepo Xue Yanjiu. 2011;33(2):95-100.
18. Clavreul A, Sindji L, Aubert-Pouëssel A, et al. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts. Eur J Pharm Biopharm. 2006;63(2):221-228.
19. Duan Y, Xu J, Lin Y, et al. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers. J Biomed Mater Res A. 2008;87(2):515-523.
20. Cu Y, Saltzman WM. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol Pharm. 2009; 6(1):173-181.
21. Xu HB. Beijing: Tsinghua University Press, 2004.
22. Yang A, Yang L, Liu W, et al. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Int J Pharm. 2007;331 (1):123-132.